Literature DB >> 7054357

Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.

G Pfaffenbach, M E Lamm, I Gigli.   

Abstract

Activation of the complement system by IgA was investigated with immune complexes containing a mouse IgA myeloma protein with specificity for phosphorylcholine linked to bovine serum albumin (PC-BSA). These IgA anti-PC-BSA immune complexes activated the alternative complement pathway in mouse and guinea pig serum, while human complement was not affected. The activation proceeded with consumption of C3 but little or no consumption of C5. C3 did not bind to the IgA immune complexes during complement activation although it did bind covalently to IgG immune complexes. It is suggested that IgA immune complexes do not supply a suitable surface for C3 binding and effective alternative pathway convertase assembly; therefore, cleavage is limited and occurs primarily in the fluid phase. Without C3 binding, C5 cleavage does not occur nor can the alternative pathway activation proceed to the amplification step.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054357      PMCID: PMC2186569          DOI: 10.1084/jem.155.1.231

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  49 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

3.  Protein iodination with solid state lactoperoxidase.

Authors:  G S David; R A Reisfeld
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

4.  The relative antibacterial efficiency of IgM, IgG and IgA from pig colostrum.

Authors:  J Knop; H Breu; P Wernet; D Rowley
Journal:  Aust J Exp Biol Med Sci       Date:  1971-08

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology.

Authors:  M Takahashi; J Czop; A Ferreira; V Nussenzweig
Journal:  Transplant Rev       Date:  1976

7.  Surface and intracellular markers of mouse mesenteric and peripheral lymph node and Peyer's patch cells.

Authors:  M McWilliams; M E Lamm; J M Phillips-Quagliata
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

8.  The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Invest Dermatol       Date:  1974-08       Impact factor: 8.551

9.  Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.

Authors:  A P Dalmasso; H J Müller-Eberhard
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

10.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  24 in total

1.  Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.

Authors:  R T Meijer; S L Yong; I J ten Berge; R A van Lier; P T Schellekens
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 3.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

4.  Activation of human monocytes via their sIgA receptors.

Authors:  S Padeh; C L Jaffe; J H Passwell
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

5.  In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury.

Authors:  J S Warren; S L Kunkel; K J Johnson; P A Ward
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

6.  Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.

Authors:  S J Challacombe; D Rahman; H Jeffery; S S Davis; D T O'Hagan
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

Review 7.  Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases.

Authors:  M Kilian; J Mestecky; M W Russell
Journal:  Microbiol Rev       Date:  1988-06

8.  IgA and IgG immune complexes increase human macrophage C3 biosynthesis.

Authors:  J Laufer; H Boichis; N Farzam; J H Passwell
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

9.  Acute lung injury in rat caused by immunoglobulin A immune complexes.

Authors:  K J Johnson; B S Wilson; G O Till; P A Ward
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; A Darvill; F W Ballardie
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.